Lifeboat Foundation

In 1,868, Jean-Martin Charcot, a neurologist at the Hôpital de Salpétrière in France, first coined the disease “la sclérose en plaques,” which means multiple sclerosis (MS) — to distinguish it from another type of movement disorder later known as Parkinson’s disease.

Though described in 1,868, the cause of MS puzzled scientists for more than a century. This is until a 2022 breakthrough study finally enlightens us that the cause is, oddly, the seemingly innocent Epstein-Barr virus (EBV), a common childhood virus that causes typical fever and sore throat.

Let’s see how one study single-handedly proves what we thought couldn’t be proved; how one study truly deserves to be called a breakthrough; and how thorough and near-perfect science is done.

The engineers believe that their method, referred to as superluminescent light projection, represents a breakthrough that could enable revolutionary technological advancements in a wide range of industrial, commercial, and scientific applications, including advances in nanotechnology.

Printing Infinitesimally Small Objects by Harnessing the Power of Light

As technologies continue to advance, scientists and engineers have developed an increasing need for objects printed at the nanoscale, meaning hundreds of times smaller than a human hair. This is especially true in extremely advanced nanotechnologies like power generation and sensing, as well as novel medical procedures that previously only existed in science fiction.

Instruments smaller than a human hair are being designed to eradicate antibiotic-resistant bacteria and fight cancer.

Dr. Ana Santos becomes emotional when describing what happened several years ago: Her grandfather and an uncle died of urinary tract infections and a good friend succumbed after an accidental cut got infected.

She was shocked. In an age of antibiotics, such misfortunes weren’t supposed to happen.

Bonn researchers identify protein that increases the formation of good brown and beige fat. Brown fat cells convert energy into heat — a key to eliminating unwanted fat deposits. In addition, they also protect against cardiovascular diseases. Researchers from the University Hospital Bonn (UKB) and the Transdisciplinary Research Area “Life & Health” at the University of Bonn have now identified the protein EPAC1 as a new pharmacological target to increase brown fat mass and activity. The long-term aim is to find medicines that support weight loss. The results of the study have now been published in the journal Nature Cell Biology.

Obesity is defined as a pathological increase in white fat, and has become a major problem worldwide, with a greatly increased risk of cardiovascular diseases such as heart attack and stroke.

“Exercise and dieting are not enough to effectively and permanently shed the pounds,” says corresponding author Prof.

The various identities of cells, whether they are in the brain, heart, kidney, or any other tissue, are defined by the genes they expressed. In basic terms, the genes that are active in a cell are transcribed into RNA molecules that are then translated into proteins using tRNA molecules. In the genetic code, three base pair sequences of DNA, or codons, represent amino acids. These amino acids are moved into place by tRNA molecules, which have matching anticodons, to make proteins. There is redundancy in the genetic code as well, in which one amino acid can often be encoded by a few different codons.

Protein production varies considerably in different cells, and this is especially notable in cells that generate antibodies. These cells often have to spring into action and shift into high gear to generate many infection-fighting antibodies quickly. These antibody producers are B cells, and they often make significant metabolic adaptations when they’re needed.

This finding has important implications for cancer research, as HR is involved in many aspects of cancer biology.

Unlocking the secrets for living more years disease-free is increasingly the target for longevity researchers.

Its AI model can predict the accumulation of amyloid-beta protein, a major Alzheimer’s biomarker.

Experts created robotic arms to conduct essential medical triage in perilous situations like humanitarian disasters and conflict zones.

Developed by researchers at the University of Sheffield, this revolutionary technology has the potential to be a life-saving intervention in high-risk places.

Examining victims within 20 minutes

Continue reading “Experts craft life-saving ‘robot medics’ for triage in high-risk places” »